48 results on '"Kalidindi, Teja"'
Search Results
2. Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
3. CEACAM5-Targeted Immuno-PET in Androgen Receptor–Negative Prostate Cancer
4. Synthesis of carbohydrate analogues of the THF-acetogenin 4-deoxyannomontacin and their cytotoxicity against human prostate cancer cell lines
5. Development of a PSMA Heterogeneous Tumor Model for Targeted Radiotherapy
6. Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system
7. Unraveling the Mechanism of Epichaperome Modulation by Zelavespib: Biochemical Insights on Target Occupancy and Extended Residence Time at the Site of Action
8. Supplementary Figures 1 and 2 from Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
9. Data from Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
10. Copper-64 labeled liposomes for imaging bone marrow
11. P-286 - Development of a PSMA Heterogeneous Tumor Model for Targeted Radiotherapy
12. Table S2 from Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe
13. Supplementary Figure S1 from PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
14. Figure S2 from Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe
15. Data from Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe
16. Supplementary Methods from PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
17. NMR and HRMS from Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe
18. Supplementary Table S1 from PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
19. Targeting Carbohydrate Mimetics of Tetrahydrofuran-Containing Acetogenins to Prostate Cancer
20. Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
21. Tetrahydroprotoberberine alkaloids with dopamine and σ receptor affinity
22. Repeatability of [68Ga]DKFZ11-PSMA PET Scans for Detecting Prostate-specific Membrane Antigen-positive Prostate Cancer
23. Assessing Functional Androgen Receptor Pathway Activity in Response to Radiotherapy Using hK2-targeted PET Imaging
24. Synthesis of 124I-labeled epichaperome probes and assessment in visualizing pathologic protein-protein interaction networks in tumor bearing mice
25. Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3
26. Synthesis of Carbohydrate Analogues of the THF-Acetogenin 4-Deoxyannomontacin and Their Cytotoxicity Against Human Prostate Cancer Cell Lines
27. Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells
28. Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe
29. Abstract 979: Bcl-2 inhibitor enhances anti-androgen therapy induced regression of castration sensitive prostate cancer
30. Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer.
31. A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals
32. PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
33. Erratum to: Repeatability of [68Ga]DKFZ11-PSMA PET Scans for Detecting Prostate-specific Membrane Antigen-positive Prostate Cancer
34. PSA-targeted Alpha-, Beta- and Positron Emitting Immuno-Theranostics in Murine Prostate Cancer Models and Non-Human Primates
35. γ-Tocotrienol–Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs
36. Abstract 1650: Non-invasive imaging tool to predict BRCA2 silencing in the context of prostate cancer
37. A simple strategy to reduce the salivary gland and kidney uptake of PSMA targeting small molecule radiopharmaceuticals
38. Predicting Gemcitabine Delivery by 18F-FAC PET in Murine Models of Pancreatic Cancer
39. Genetic signature of prostate cancer resistant to optimized hK2 targeted alpha-particle therapy
40. Predicting gemcitabine delivery by 18F-FAC PET in murine models of pancreatic cancer.
41. Gamma-Tocotrienol loaded liposomes as radioprotection from hematopoietic side effects caused by radiotherapeutic drugs.
42. Gamma-Tocotrienol loaded liposomes as radioprotection from hematopoietic side effects caused by radiotherapeutic drugs.
43. Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
44. Repeatability of [68Ga]DKFZ11-PSMA PET Scans for Detecting Prostate-specific Membrane Antigen-positive Prostate Cancer.
45. In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME)
46. Synthesis of 124 I-labeled epichaperome probes and assessment in visualizing pathologic protein-protein interaction networks in tumor bearing mice.
47. γ-Tocotrienol-Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs.
48. Predicting Gemcitabine Delivery by 18 F-FAC PET in Murine Models of Pancreatic Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.